137 related articles for article (PubMed ID: 38382699)
1. Can we predict menopause and premature ovarian insufficiency?
Laven JSE; Louwers YV
Fertil Steril; 2024 May; 121(5):737-741. PubMed ID: 38382699
[TBL] [Abstract][Full Text] [Related]
2. Anti-Müllerian Hormone in the Diagnosis and Prediction of Premature Ovarian Insufficiency.
Anderson RA; Nelson SM
Semin Reprod Med; 2020 Sep; 38(4-05):263-269. PubMed ID: 33429444
[TBL] [Abstract][Full Text] [Related]
3. Ovarian Reserve Markers in Premature Ovarian Insufficiency: Within Different Clinical Stages and Different Etiologies.
Jiao X; Meng T; Zhai Y; Zhao L; Luo W; Liu P; Qin Y
Front Endocrinol (Lausanne); 2021; 12():601752. PubMed ID: 33815272
[TBL] [Abstract][Full Text] [Related]
4. Very Low Levels of Serum Anti-Müllerian Hormone as a Possible Marker for Follicle Growth in Patients with Primary Ovarian Insufficiency Under Hormone Replacement Therapy.
Kasahara Y; Osuka S; Bayasula ; Nakanishi N; Murase T; Nakamura T; Goto M; Kotani T; Iwase A; Kikkawa F
Reprod Sci; 2021 Jan; 28(1):31-36. PubMed ID: 32737737
[TBL] [Abstract][Full Text] [Related]
5. Role of AMH in Prediction of Menopause.
de Kat AC; Broekmans FJM; Lambalk CB
Front Endocrinol (Lausanne); 2021; 12():733731. PubMed ID: 34594304
[TBL] [Abstract][Full Text] [Related]
6. The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer.
Anderson RA; Mansi J; Coleman RE; Adamson DJA; Leonard RCF
Eur J Cancer; 2017 Dec; 87():58-64. PubMed ID: 29117576
[TBL] [Abstract][Full Text] [Related]
7. Improving Prediction of Age at Menopause Using Multiple Anti-Müllerian Hormone Measurements: the Tehran Lipid-Glucose Study.
Ramezani Tehrani F; Bidhendi Yarandi R; Solaymani-Dodaran M; Tohidi M; Firouzi F; Azizi F
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32109280
[TBL] [Abstract][Full Text] [Related]
8. Maternal menopause as a predictor of anti-Mullerian hormone level and antral follicle count in daughters during reproductive age.
Bentzen JG; Forman JL; Larsen EC; Pinborg A; Johannsen TH; Schmidt L; Friis-Hansen L; Nyboe Andersen A
Hum Reprod; 2013 Jan; 28(1):247-55. PubMed ID: 23136135
[TBL] [Abstract][Full Text] [Related]
9. Demographic, clinical and hormonal characteristics of patients with premature ovarian insufficiency and those of early menopause: data from two tertiary premature ovarian insufficiency centers in Greece.
Bompoula MS; Valsamakis G; Neofytou S; Messaropoulos P; Salakos N; Mastorakos G; Kalantaridou SN
Gynecol Endocrinol; 2020 Aug; 36(8):693-697. PubMed ID: 32208770
[TBL] [Abstract][Full Text] [Related]
10. Menstrual cycle characteristics of young females with occult primary ovarian insufficiency at initial diagnosis and one-year follow-up with serum amh level and antral follicle count.
Guzel Y; Aba YA; Yakin K; Oktem O
PLoS One; 2017; 12(11):e0188334. PubMed ID: 29176793
[TBL] [Abstract][Full Text] [Related]
11. Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic review.
Nelson SM; Davis SR; Kalantaridou S; Lumsden MA; Panay N; Anderson RA
Hum Reprod Update; 2023 May; 29(3):327-346. PubMed ID: 36651193
[TBL] [Abstract][Full Text] [Related]
12. Association study of anti-Mullerian hormone and anti-Mullerian hormone type II receptor polymorphisms with idiopathic primary ovarian insufficiency.
Yoon SH; Choi YM; Hong MA; Kim JJ; Lee GH; Hwang KR; Moon SY
Hum Reprod; 2013 Dec; 28(12):3301-5. PubMed ID: 24146295
[TBL] [Abstract][Full Text] [Related]
13. Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency.
Visser JA; Schipper I; Laven JS; Themmen AP
Nat Rev Endocrinol; 2012 Jan; 8(6):331-41. PubMed ID: 22231848
[TBL] [Abstract][Full Text] [Related]
14. Serum anti-Mullerian hormone (AMH) concentration has limited prognostic value for density of primordial and primary follicles, questioning it as an accurate parameter for the ovarian reserve.
von Wolff M; Roumet M; Stute P; Liebenthron J
Maturitas; 2020 Apr; 134():34-40. PubMed ID: 32143774
[TBL] [Abstract][Full Text] [Related]
15. Study of Serum Anti-Mullerian Hormone in the Diagnosis of Ovarian Reserve Function in Patients with Premature Ovarian Insufficiency.
Cai Y; Zhang Q; Yu K; Wang Q
Biomed Res Int; 2022; 2022():3878359. PubMed ID: 36277874
[TBL] [Abstract][Full Text] [Related]
16. Does anti-Müllerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study.
Depmann M; Eijkemans MJ; Broer SL; Scheffer GJ; van Rooij IA; Laven JS; Broekmans FJ
Hum Reprod; 2016 Jul; 31(7):1579-87. PubMed ID: 27179263
[TBL] [Abstract][Full Text] [Related]
17. Bone health in women with premature ovarian insufficiency/early menopause: a 23-year longitudinal analysis.
Jones AR; Enticott J; Ebeling PR; Mishra GD; Teede HT; Vincent AJ
Hum Reprod; 2024 May; 39(5):1013-1022. PubMed ID: 38396142
[TBL] [Abstract][Full Text] [Related]
18. Undetectable antimüllerian hormone levels and recovery of chemotherapy-induced ovarian failure in women with breast cancer on an oral aromatase inhibitor.
Dieudonné AS; Vandenberghe J; Geerts I; Billen J; Paridaens R; Wildiers H; Neven P
Menopause; 2011 Jul; 18(7):821-4. PubMed ID: 21326118
[TBL] [Abstract][Full Text] [Related]
19. The cardiovascular risk profile of middle age women previously diagnosed with premature ovarian insufficiency: A case-control study.
Gunning MN; Meun C; van Rijn BB; Daan NMP; Roeters van Lennep JE; Appelman Y; Boersma E; Hofstra L; Fauser CGKM; Rueda-Ochoa OL; Ikram MA; Kavousi M; Lambalk CB; Eijkemans MJC; Laven JSE; Fauser BCJM;
PLoS One; 2020; 15(3):e0229576. PubMed ID: 32134933
[TBL] [Abstract][Full Text] [Related]
20. The physiology and clinical utility of anti-Mullerian hormone in women.
Dewailly D; Andersen CY; Balen A; Broekmans F; Dilaver N; Fanchin R; Griesinger G; Kelsey TW; La Marca A; Lambalk C; Mason H; Nelson SM; Visser JA; Wallace WH; Anderson RA
Hum Reprod Update; 2014; 20(3):370-85. PubMed ID: 24430863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]